首页 > 最新文献

Clinical laboratory最新文献

英文 中文
Progress in the Mechanism of Hyperhomocysteinemia-Induced Renal Injury. 高同型半胱氨酸血症致肾损伤机制的研究进展。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250335
Jin Zhang, Dagong Zhang, Zhen Xu, Yiming Wang, Xiaosong Qin

Background: Hcy is a sulfhydryl amino acid in the metabolism of methionine. It has been recognized as an independent risk factor for cardiovascular disease. In recent years, the relationship between hyperhomocysteinemia and renal disease has received attention from many researchers. However, the specific mechanisms by which Hcy plays a role in cardiovascular pathology in patients with chronic kidney disease are complex.

Methods: We consulted the relevant literature and sorted and summarized it.

Results: Multiple mechanisms of hyperhomocysteinemia-induced renal injury are summarized in detail from different perspectives, including oxidative stress, vascular endothelial damage, inflammatory response, cellular autophagy, apoptosis, fibrosis, and epigenetic regulation.

Conclusions: Hyperhomocysteinemia acts synergistically through multiple pathways, leading to glomerulosclerosis, tubular atrophy, and interstitial fibrosis, and ultimately accelerating renal failure. These mechanisms are complex and interrelated, suggesting that a comprehensive intervention strategy may achieve the ultimate goal of reducing renal injury.

背景:Hcy是蛋氨酸代谢中的一种巯基氨基酸。它已被认为是心血管疾病的独立危险因素。近年来,高同型半胱氨酸血症与肾脏疾病的关系受到了许多研究者的关注。然而,Hcy在慢性肾病患者心血管病理中发挥作用的具体机制是复杂的。方法:查阅相关文献,进行整理总结。结果:从氧化应激、血管内皮损伤、炎症反应、细胞自噬、细胞凋亡、纤维化和表观遗传调控等不同角度详细总结了高同型半胱氨酸血症致肾损伤的多种机制。结论:高同型半胱氨酸血症通过多种途径协同作用,导致肾小球硬化、小管萎缩和间质纤维化,最终加速肾功能衰竭。这些机制复杂且相互关联,表明综合干预策略可能达到减少肾损伤的最终目标。
{"title":"Progress in the Mechanism of Hyperhomocysteinemia-Induced Renal Injury.","authors":"Jin Zhang, Dagong Zhang, Zhen Xu, Yiming Wang, Xiaosong Qin","doi":"10.7754/Clin.Lab.2025.250335","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250335","url":null,"abstract":"<p><strong>Background: </strong>Hcy is a sulfhydryl amino acid in the metabolism of methionine. It has been recognized as an independent risk factor for cardiovascular disease. In recent years, the relationship between hyperhomocysteinemia and renal disease has received attention from many researchers. However, the specific mechanisms by which Hcy plays a role in cardiovascular pathology in patients with chronic kidney disease are complex.</p><p><strong>Methods: </strong>We consulted the relevant literature and sorted and summarized it.</p><p><strong>Results: </strong>Multiple mechanisms of hyperhomocysteinemia-induced renal injury are summarized in detail from different perspectives, including oxidative stress, vascular endothelial damage, inflammatory response, cellular autophagy, apoptosis, fibrosis, and epigenetic regulation.</p><p><strong>Conclusions: </strong>Hyperhomocysteinemia acts synergistically through multiple pathways, leading to glomerulosclerosis, tubular atrophy, and interstitial fibrosis, and ultimately accelerating renal failure. These mechanisms are complex and interrelated, suggesting that a comprehensive intervention strategy may achieve the ultimate goal of reducing renal injury.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707647","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics of Protein S in Koreans by Age and Gender: a Retrospective Analysis based on Results from Korean Referral Laboratories. 韩国人蛋白质S的年龄和性别特征:基于韩国转诊实验室结果的回顾性分析。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250451
Min J Na, Jae K Kim

Background: Protein S, a vitamin K-dependent protein, is crucial in inhibiting blood clotting, and its deficiency increases the risk of thrombotic disease. However, most studies have focused on Western populations. Although Koreans have a lower incidence of thrombotic diseases, the risk is rising due to aging and Westernized lifestyle habits. Therefore, protein S levels should be investigated in Koreans for developing strategies to prevent and manage thrombotic diseases. This study aimed to analyze protein S-related data according to age and gender in Korean adults.

Methods: This retrospective study examined protein S activity and free protein S levels from January 2017 through December 2023 in Korean adults, using data from commissioned inspection institutions in Korea. Protein S activity was measured using a coagulation-based assay, while free protein S levels were determined via immunoturbidimetric analysis. Data were categorized by year, gender, age group, and type of protein S deficiency, and trends in test values and frequency were analyzed.

Results: A total of 2,470 individuals (907 men and 1,563 women) were included. Protein S activity increased with age until 50 - 59 years, then declined, whereas free protein S levels peaked at 70 - 79 years before slightly decreasing. The number of protein S tests increased steadily over the years, with consistently more tests performed in women than in men throughout. Women showed significantly lower levels of both protein S activity and free protein S than men (p < 0.001), and a strong significant positive correlation was observed between the two protein S activity and free protein S tests (R = 0.543, p < 0.001). Deficiency patterns were classified into three groups based on test results. Among these, the most prevalent group (39.3%) had decreased protein S activity with normal free protein S, particularly among women and individuals aged 20 - 39 years.

Conclusions: This study provides critical reference data on protein S levels in Koreans, highlighting significant age- and gender-related differences. These findings contribute to refining thrombotic risk assessment in Korean populations and complement existing Western-based studies. Further research incorporating clinical histories is warranted to enhance the clinical applicability of protein S testing.

背景:蛋白S,一种维生素k依赖性蛋白,在抑制血液凝固中起着至关重要的作用,其缺乏会增加血栓性疾病的风险。然而,大多数研究都集中在西方人群身上。虽然韩国人的血栓性疾病发病率较低,但由于老龄化和西方化的生活习惯,风险正在上升。因此,应该研究韩国人的蛋白S水平,以制定预防和管理血栓性疾病的策略。该研究的目的是分析韩国成年人中不同年龄和性别的蛋白质s相关数据。方法:本回顾性研究使用韩国委托检测机构的数据,检测了2017年1月至2023年12月韩国成年人的蛋白S活性和游离蛋白S水平。蛋白S活性采用凝固法测定,游离蛋白S水平采用免疫比浊法测定。数据按年份、性别、年龄组和蛋白质S缺乏症类型分类,并分析检测值和频率的趋势。结果:共纳入2470人(男性907人,女性1563人)。蛋白质S活性随着年龄的增长而增加,直到50 ~ 59岁,然后下降,而游离蛋白S水平在70 ~ 79岁达到峰值,然后略有下降。多年来,蛋白S检测的数量稳步增加,在整个过程中,女性检测的数量一直比男性多。女性蛋白S活性和游离蛋白S水平均显著低于男性(p < 0.001),且两项蛋白S活性和游离蛋白S检测结果呈显著正相关(R = 0.543, p < 0.001)。根据测试结果,将缺陷类型分为三组。其中,最常见的组(39.3%)蛋白S活性降低,游离蛋白S正常,特别是在女性和20 - 39岁的个体中。结论:这项研究提供了韩国人蛋白质S水平的关键参考数据,突出了与年龄和性别相关的显著差异。这些发现有助于完善韩国人群的血栓风险评估,并补充现有的西方研究。进一步的研究应结合临床病史,以提高蛋白S检测的临床适用性。
{"title":"Characteristics of Protein S in Koreans by Age and Gender: a Retrospective Analysis based on Results from Korean Referral Laboratories.","authors":"Min J Na, Jae K Kim","doi":"10.7754/Clin.Lab.2025.250451","DOIUrl":"10.7754/Clin.Lab.2025.250451","url":null,"abstract":"<p><strong>Background: </strong>Protein S, a vitamin K-dependent protein, is crucial in inhibiting blood clotting, and its deficiency increases the risk of thrombotic disease. However, most studies have focused on Western populations. Although Koreans have a lower incidence of thrombotic diseases, the risk is rising due to aging and Westernized lifestyle habits. Therefore, protein S levels should be investigated in Koreans for developing strategies to prevent and manage thrombotic diseases. This study aimed to analyze protein S-related data according to age and gender in Korean adults.</p><p><strong>Methods: </strong>This retrospective study examined protein S activity and free protein S levels from January 2017 through December 2023 in Korean adults, using data from commissioned inspection institutions in Korea. Protein S activity was measured using a coagulation-based assay, while free protein S levels were determined via immunoturbidimetric analysis. Data were categorized by year, gender, age group, and type of protein S deficiency, and trends in test values and frequency were analyzed.</p><p><strong>Results: </strong>A total of 2,470 individuals (907 men and 1,563 women) were included. Protein S activity increased with age until 50 - 59 years, then declined, whereas free protein S levels peaked at 70 - 79 years before slightly decreasing. The number of protein S tests increased steadily over the years, with consistently more tests performed in women than in men throughout. Women showed significantly lower levels of both protein S activity and free protein S than men (p < 0.001), and a strong significant positive correlation was observed between the two protein S activity and free protein S tests (R = 0.543, p < 0.001). Deficiency patterns were classified into three groups based on test results. Among these, the most prevalent group (39.3%) had decreased protein S activity with normal free protein S, particularly among women and individuals aged 20 - 39 years.</p><p><strong>Conclusions: </strong>This study provides critical reference data on protein S levels in Koreans, highlighting significant age- and gender-related differences. These findings contribute to refining thrombotic risk assessment in Korean populations and complement existing Western-based studies. Further research incorporating clinical histories is warranted to enhance the clinical applicability of protein S testing.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Features and Prognosis Analysis of Acute Myeloid Leukemia in Children with DEK-CAN-Positive. dek - can阳性儿童急性髓性白血病的临床特点及预后分析。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250453
Jiajia Li, Xi Yuan, Chun Liang, Lei Zhang, Zhen Li

Background: The goal of the study is to investigate the clinical characteristics and prognostic analysis of acute myeloid leukemia in children with positive DEK-CAN fusion gene.

Methods: The clinical characteristics and prognostic analysis methods of a case of acute myeloid leukemia in children with positive DEK-CAN fusion gene were retrospectively analyzed, and the domestic and international literature was reviewed.

Results: The patient is a girl, 11 years old. The clinical diagnosis was acute myeloid leukemia M2a. Liver full, spleen large, a few small lymph nodes in bilateral axilla and retroperitoneum. Blood routine: WBC: 34.49 x 10⁹/L, RBC: 0.91 x 10¹²/L, Hb: 30g/L, Plt: 26 x 10⁹/L, the proportion of leukocyte classification granulocyte was significantly increased, and the primitive naive granulocyte accounted for 56%. Bone marrow smear: primitive naive myelodysplasia, 74% of myeloid original cells, large cell body, moderate plasma volume, round or irregular nuclei, fine nuclear chromatin, visible nucleoli. Peroxidase (MPO) staining: positive. Immunophenotypic expression of antigens CD117, HLA-DR, CD13, CD33, CD123, partial expression of antigens CD34, CD38, abnormal myeloid original cells. Patients tested by fusion gene were positive for DEK-CAN with FLT3-ITD mutation. The clinical di-agnosis was acute myeloid leukemia M2a. Chromosome karyotype analysis showed no split phase. The IA regimen, FLAG regimen, and HIA regimen were given successively, and no remission was achieved.

Conclusions: Patients with DEK-CAN fusion gene positive AML have a very poor prognosis, low primary induced remission rate, and high mortality. For confirmed cases, patients in remission with chemotherapy should undergo allogeneic hematopoietic stem cell transplantation as soon as possible to have a chance of long-term survival.

背景:本研究旨在探讨DEK-CAN融合基因阳性儿童急性髓系白血病的临床特点及预后分析。方法:回顾性分析1例DEK-CAN融合基因阳性儿童急性髓性白血病的临床特点及预后分析方法,并复习国内外相关文献。结果:患者为女童,年龄11岁。临床诊断为急性髓性白血病M2a。肝饱满,脾大,双侧腋窝和腹膜后有少量小淋巴结。血常规:WBC: 34.49 x 10⁹/L, RBC: 0.91 x 10¹²/L, Hb: 30g/L, Plt: 26 x 10⁹/L,白细胞分类粒细胞比例显著增加,原始幼稚粒细胞占56%。骨髓涂片:原始幼稚骨髓发育不良,74%髓系原始细胞,胞体大,血浆容量中等,细胞核圆形或不规则,核染色质细,可见核仁。过氧化物酶(MPO)染色:阳性。抗原CD117、HLA-DR、CD13、CD33、CD123的免疫表型表达,抗原CD34、CD38的部分表达,异常髓原细胞。融合基因检测患者DEK-CAN阳性,FLT3-ITD突变。临床诊断为急性髓性白血病M2a。染色体核型分析显示无分裂期。先后给予IA方案、FLAG方案、HIA方案,均未达到缓解。结论:DEK-CAN融合基因阳性AML患者预后极差,原发诱导缓解率低,死亡率高。对于确诊病例,化疗缓解期患者应尽快进行异基因造血干细胞移植,以获得长期生存的机会。
{"title":"Clinical Features and Prognosis Analysis of Acute Myeloid Leukemia in Children with DEK-CAN-Positive.","authors":"Jiajia Li, Xi Yuan, Chun Liang, Lei Zhang, Zhen Li","doi":"10.7754/Clin.Lab.2025.250453","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250453","url":null,"abstract":"<p><strong>Background: </strong>The goal of the study is to investigate the clinical characteristics and prognostic analysis of acute myeloid leukemia in children with positive DEK-CAN fusion gene.</p><p><strong>Methods: </strong>The clinical characteristics and prognostic analysis methods of a case of acute myeloid leukemia in children with positive DEK-CAN fusion gene were retrospectively analyzed, and the domestic and international literature was reviewed.</p><p><strong>Results: </strong>The patient is a girl, 11 years old. The clinical diagnosis was acute myeloid leukemia M2a. Liver full, spleen large, a few small lymph nodes in bilateral axilla and retroperitoneum. Blood routine: WBC: 34.49 x 10⁹/L, RBC: 0.91 x 10¹²/L, Hb: 30g/L, Plt: 26 x 10⁹/L, the proportion of leukocyte classification granulocyte was significantly increased, and the primitive naive granulocyte accounted for 56%. Bone marrow smear: primitive naive myelodysplasia, 74% of myeloid original cells, large cell body, moderate plasma volume, round or irregular nuclei, fine nuclear chromatin, visible nucleoli. Peroxidase (MPO) staining: positive. Immunophenotypic expression of antigens CD117, HLA-DR, CD13, CD33, CD123, partial expression of antigens CD34, CD38, abnormal myeloid original cells. Patients tested by fusion gene were positive for DEK-CAN with FLT3-ITD mutation. The clinical di-agnosis was acute myeloid leukemia M2a. Chromosome karyotype analysis showed no split phase. The IA regimen, FLAG regimen, and HIA regimen were given successively, and no remission was achieved.</p><p><strong>Conclusions: </strong>Patients with DEK-CAN fusion gene positive AML have a very poor prognosis, low primary induced remission rate, and high mortality. For confirmed cases, patients in remission with chemotherapy should undergo allogeneic hematopoietic stem cell transplantation as soon as possible to have a chance of long-term survival.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation Analysis of HIV Infection Epidemiology and Detection Characteristics Among Voluntary Blood Donators in Hefei City. 合肥市无偿献血者HIV感染流行病学与检测特征的相关性分析
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250133
Yun Zhang, Min Zhang, Weifang Cheng, Jinxing Xia

Background: This study aimed to explore the characteristics of HIV infection prevalence and laboratory detection results among voluntary non-remunerated blood donators in Hefei.

Methods: Statistical analyses were performed on 609,230 blood samples from blood donation volunteers receiving HIV screening tests in Blood Center of Anhui Province from 2017 through 2021. Blood samples were screened and/or confirmed by HIV ELISA, nucleic acid testing (NAT), and western blotting (WB)-based HIV confirmation detection if appropriate. The reactive rates, correlation, and consistency of HIV ELISA screening and WB confir-mation tests as well as NAT were comprehensively analyzed in a large scale. The efficacies of HIV ELISA reagents were assessed through ROC curve analyses.

Results: The WB confirmed HIV-positive rate averaged 0.013% (80/609,230) among the blood donation cases between 2017 and 2021. In the HIV-positive population, the gender ratio (male to female) was over 25, the age group of 18 - 30 years was predominant, with blood group types of mainly A and B, and most were office employees and students. The total number of HIV preliminary screening tests with reactive results by two ELISA reagents (reagent 1 and reagent 2) amounted to 1,948 (0.320%), with 1,828 of single-reagent reactive and 120 of double-reagent reactive. The HIV ELISA initial and retest reactive rates for reagent 1 vs. reagent 2 were 0.077% vs. 0.405% (p < 0.001) and 0.054% vs. 0.286% (p < 0.001), respectively, but their ELISA retest compliance rates were comparable. The ROC curve analyses showed that the area under curve (AUC) and specificity of reagent 1 were relatively higher than those of reagent 2, but both shared an identical sensitivity.

Conclusions: From 2017 through 2021, the local participation of voluntary non-remunerated blood donation showed an overall increasing trend, and the HIV infection prevalence maintained relatively stable in the blood donating population, with the infected individuals being dominated by sexually active young male office employees and students. There existed certain differences in the screening efficacies of distinct HIV ELISA reagents. The au-thorized laboratories should comprehensively evaluate the selection of blood screening programs and reagents to effectively conserve blood resources and reduce the risk of blood-borne HIV transmission.

背景:本研究旨在了解合肥市无偿献血者HIV感染流行特征及实验室检测结果。方法:对2017 - 2021年安徽省血液中心接受HIV筛查的609230份献血志愿者血液样本进行统计分析。血液样本通过HIV ELISA、核酸检测(NAT)和基于免疫印迹(WB)的HIV确认检测进行筛选和/或确认。大规模综合分析HIV ELISA筛查、WB确认试验与NAT的反应率、相关性和一致性。采用ROC曲线分析评价HIV ELISA试剂的疗效。结果:2017 - 2021年献血病例WB确诊hiv阳性率平均为0.013%(80/ 609230)。hiv阳性人群性别比例(男女)大于25岁,年龄在18 - 30岁之间,血型以A型和B型为主,以办公室职员和学生居多。2种ELISA试剂(试剂1和试剂2)的HIV初筛检测结果阳性的共有1948例(0.20%),其中单试剂阳性1828例,双试剂阳性120例。试剂1与试剂2的HIV ELISA初始反应率和重测反应率分别为0.077%对0.405% (p < 0.001)和0.054%对0.286% (p < 0.001),但其ELISA重测依从率相当。ROC曲线分析显示,试剂1的曲线下面积(AUC)和特异性相对高于试剂2,但两者具有相同的灵敏度。结论:2017 - 2021年,当地自愿无偿献血人数总体呈上升趋势,献血人群中HIV感染流行率保持相对稳定,感染人群以性活跃的年轻男性办公室职员和学生为主。不同HIV ELISA试剂的筛选效果存在一定差异。授权实验室应综合评价血液筛查方案和试剂的选择,以有效节约血液资源,降低血源性HIV传播风险。
{"title":"Correlation Analysis of HIV Infection Epidemiology and Detection Characteristics Among Voluntary Blood Donators in Hefei City.","authors":"Yun Zhang, Min Zhang, Weifang Cheng, Jinxing Xia","doi":"10.7754/Clin.Lab.2025.250133","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250133","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to explore the characteristics of HIV infection prevalence and laboratory detection results among voluntary non-remunerated blood donators in Hefei.</p><p><strong>Methods: </strong>Statistical analyses were performed on 609,230 blood samples from blood donation volunteers receiving HIV screening tests in Blood Center of Anhui Province from 2017 through 2021. Blood samples were screened and/or confirmed by HIV ELISA, nucleic acid testing (NAT), and western blotting (WB)-based HIV confirmation detection if appropriate. The reactive rates, correlation, and consistency of HIV ELISA screening and WB confir-mation tests as well as NAT were comprehensively analyzed in a large scale. The efficacies of HIV ELISA reagents were assessed through ROC curve analyses.</p><p><strong>Results: </strong>The WB confirmed HIV-positive rate averaged 0.013% (80/609,230) among the blood donation cases between 2017 and 2021. In the HIV-positive population, the gender ratio (male to female) was over 25, the age group of 18 - 30 years was predominant, with blood group types of mainly A and B, and most were office employees and students. The total number of HIV preliminary screening tests with reactive results by two ELISA reagents (reagent 1 and reagent 2) amounted to 1,948 (0.320%), with 1,828 of single-reagent reactive and 120 of double-reagent reactive. The HIV ELISA initial and retest reactive rates for reagent 1 vs. reagent 2 were 0.077% vs. 0.405% (p < 0.001) and 0.054% vs. 0.286% (p < 0.001), respectively, but their ELISA retest compliance rates were comparable. The ROC curve analyses showed that the area under curve (AUC) and specificity of reagent 1 were relatively higher than those of reagent 2, but both shared an identical sensitivity.</p><p><strong>Conclusions: </strong>From 2017 through 2021, the local participation of voluntary non-remunerated blood donation showed an overall increasing trend, and the HIV infection prevalence maintained relatively stable in the blood donating population, with the infected individuals being dominated by sexually active young male office employees and students. There existed certain differences in the screening efficacies of distinct HIV ELISA reagents. The au-thorized laboratories should comprehensively evaluate the selection of blood screening programs and reagents to effectively conserve blood resources and reduce the risk of blood-borne HIV transmission.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteonecrosis of Femoral Head with Antiphospholipid Syndrome and Acquired Subclinical Hemophilia A. 股骨头坏死合并抗磷脂综合征和获得性亚临床血友病A。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250342
Qianyuan Luo, Zhenglian Luo, Yonghuai Yang

Background: Osteonecrosis of the femoral head is a common orthopedic disease, usually caused by traumatic and non-traumatic factors. Antiphospholipid syndrome (APS) is an autoimmune disorder marked by the persistent presence of antiphospholipid antibodies (aPL). Acquired subclinical hemophilia A is a subset of acquired hemophilia A. The content of factor VIII often drops to the subclinical range due to the inhibitor of factor VIII produced by certain autoimmune diseases. Here, we report a rare case of osteonecrosis of the femoral head with APS and subclinical hemophilia A.

Methods: The patient was diagnosed with bilateral femoral head necrosis according to clinical symptoms and imaging findings. APS and subclinical hemophilia A were diagnosed based on a coagulation function test, APTT correction experiment, antiphospholipid antibody detection, thromboelastogram and coagulation factor activity and inhibitor detection.

Results: The above test results confirmed the presence of both antiphospholipid antibodies and factor inhibitors in the patient, which is rare clinically. The diagnosis of femoral head necrosis with antiphospholipid syndrome and acquired subclinical hemophilia A was established.

Conclusions: Such cases are extremely rare, relevant experimental results are complex, and misdiagnosis and mistreatment are common clinically. We report this case to remind clinicians and blood transfusion department staff to focus on coagulation experiments and related diseases, avoid misdiagnosis and delayed diagnosis, and provide timely, standardized treatment to improve patient prognosis.

背景:股骨头坏死是一种常见的骨科疾病,通常由创伤性和非创伤性因素引起。抗磷脂综合征(APS)是一种以抗磷脂抗体(aPL)持续存在为特征的自身免疫性疾病。获得性亚临床血友病A是获得性血友病A的一个亚群。由于某些自身免疫性疾病产生的VIII因子抑制剂,VIII因子的含量往往下降到亚临床范围。我们报告一例罕见的股骨头坏死合并APS合并亚临床血友病a的病例。方法:根据患者的临床症状和影像学表现,诊断为双侧股骨头坏死。通过凝血功能试验、APTT校正实验、抗磷脂抗体检测、血栓弹性图、凝血因子活性及抑制剂检测,诊断APS和亚临床血友病A。结果:上述检测结果证实患者同时存在抗磷脂抗体和因子抑制剂,临床罕见。确定股骨头坏死合并抗磷脂综合征和获得性亚临床血友病A的诊断。结论:此类病例极为罕见,相关实验结果复杂,临床上常误诊误治。我们报告本病例是为了提醒临床医生和输血科工作人员重视凝血实验及相关疾病,避免误诊和延误诊断,及时、规范治疗,改善患者预后。
{"title":"Osteonecrosis of Femoral Head with Antiphospholipid Syndrome and Acquired Subclinical Hemophilia A.","authors":"Qianyuan Luo, Zhenglian Luo, Yonghuai Yang","doi":"10.7754/Clin.Lab.2025.250342","DOIUrl":"10.7754/Clin.Lab.2025.250342","url":null,"abstract":"<p><strong>Background: </strong>Osteonecrosis of the femoral head is a common orthopedic disease, usually caused by traumatic and non-traumatic factors. Antiphospholipid syndrome (APS) is an autoimmune disorder marked by the persistent presence of antiphospholipid antibodies (aPL). Acquired subclinical hemophilia A is a subset of acquired hemophilia A. The content of factor VIII often drops to the subclinical range due to the inhibitor of factor VIII produced by certain autoimmune diseases. Here, we report a rare case of osteonecrosis of the femoral head with APS and subclinical hemophilia A.</p><p><strong>Methods: </strong>The patient was diagnosed with bilateral femoral head necrosis according to clinical symptoms and imaging findings. APS and subclinical hemophilia A were diagnosed based on a coagulation function test, APTT correction experiment, antiphospholipid antibody detection, thromboelastogram and coagulation factor activity and inhibitor detection.</p><p><strong>Results: </strong>The above test results confirmed the presence of both antiphospholipid antibodies and factor inhibitors in the patient, which is rare clinically. The diagnosis of femoral head necrosis with antiphospholipid syndrome and acquired subclinical hemophilia A was established.</p><p><strong>Conclusions: </strong>Such cases are extremely rare, relevant experimental results are complex, and misdiagnosis and mistreatment are common clinically. We report this case to remind clinicians and blood transfusion department staff to focus on coagulation experiments and related diseases, avoid misdiagnosis and delayed diagnosis, and provide timely, standardized treatment to improve patient prognosis.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707569","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Screening of Metabolism-Related Biomarkers and Construction of Prognostic Models in Patients with Neuroblastoma. 神经母细胞瘤患者代谢相关生物标志物筛选及预后模型构建
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250323
Feng-Zhi Gu, Liang-Yu Mi, Bin Liu, Xian-Wu Yang, Ying-Quan Zhuo, Hua-Jian Gu

Background: Energy metabolism (EM) genes play crucial roles in tumor development and progression. While neuroblastoma (NBL) cells exhibit high proliferation rates requiring efficient energy metabolism, the underlying mechanisms remain incompletely understood.

Methods: Transcriptomic analysis of the TARGET-NBL dataset was performed to stratify samples based on EM-related gene expression. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were integrated to identify critical gene modules. Prognostic biomarkers were determined through univariate and multivariate Cox regression analyses. Functional enrichment analysis and drug prediction were conducted for the identified biomarkers. Expression levels of candidate genes (GRIA2, FBXO32, GNG12, and PHLDA2) were validated using qRT-PCR. The biological function of GNG12 was investigated through gain- and loss-of-function studies in neuroblastoma cell lines.

Results: The analysis identified 1,675 differentially expressed genes and two critical modules (MEblack and MEturquoise) through WGCNA. Four prognostic biomarkers (GRIA2, FBXO32, GNG12, and PHLDA2) were established and integrated into a nomogram with clinical parameters. Functional analysis revealed their involvement in extracellular matrix organization, DNA replication, and nucleocytoplasmic transport. Drug prediction identified potential therapeutic compounds targeting GRIA2 and FBXO32. Experimental validation demonstrated elevated expression of all four biomarkers in neuroblastoma cell lines compared to normal controls. Notably, GNG12 knockdown significantly suppressed while its overexpression enhanced proliferation and migration of SH-SY5Y cells.

Conclusions: This study identified and validated four EM-related prognostic biomarkers in neuroblastoma, with GNG12 functionally implicated in tumor cell proliferation and migration. These findings provide potential therapeutic targets and prognostic indicators for neuroblastoma management.

背景:能量代谢(EM)基因在肿瘤的发生发展中起着至关重要的作用。虽然神经母细胞瘤(NBL)细胞表现出高增殖率,需要有效的能量代谢,但其潜在机制仍不完全清楚。方法:对TARGET-NBL数据集进行转录组学分析,根据em相关基因表达对样本进行分层。结合差异表达分析和加权基因共表达网络分析(WGCNA)来识别关键基因模块。通过单因素和多因素Cox回归分析确定预后生物标志物。对鉴定的生物标志物进行功能富集分析和药物预测。采用qRT-PCR验证候选基因GRIA2、FBXO32、GNG12和PHLDA2的表达水平。通过神经母细胞瘤细胞系的功能获得和功能丧失研究,研究了GNG12的生物学功能。结果:通过WGCNA分析鉴定出1675个差异表达基因和两个关键模块(MEblack和MEturquoise)。建立了四个预后生物标志物(GRIA2, FBXO32, GNG12和PHLDA2)并将其整合到具有临床参数的nomogram中。功能分析显示它们参与细胞外基质组织、DNA复制和核胞质运输。药物预测发现了靶向GRIA2和FBXO32的潜在治疗化合物。实验验证表明,与正常对照相比,神经母细胞瘤细胞系中所有四种生物标志物的表达均有所升高。值得注意的是,GNG12敲低可显著抑制SH-SY5Y细胞的增殖和迁移,而其过表达可增强SH-SY5Y细胞的增殖和迁移。结论:本研究鉴定并验证了神经母细胞瘤中四个与em相关的预后生物标志物,GNG12在功能上与肿瘤细胞的增殖和迁移有关。这些发现为神经母细胞瘤的治疗提供了潜在的治疗靶点和预后指标。
{"title":"Screening of Metabolism-Related Biomarkers and Construction of Prognostic Models in Patients with Neuroblastoma.","authors":"Feng-Zhi Gu, Liang-Yu Mi, Bin Liu, Xian-Wu Yang, Ying-Quan Zhuo, Hua-Jian Gu","doi":"10.7754/Clin.Lab.2025.250323","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250323","url":null,"abstract":"<p><strong>Background: </strong>Energy metabolism (EM) genes play crucial roles in tumor development and progression. While neuroblastoma (NBL) cells exhibit high proliferation rates requiring efficient energy metabolism, the underlying mechanisms remain incompletely understood.</p><p><strong>Methods: </strong>Transcriptomic analysis of the TARGET-NBL dataset was performed to stratify samples based on EM-related gene expression. Differential expression analysis and weighted gene co-expression network analysis (WGCNA) were integrated to identify critical gene modules. Prognostic biomarkers were determined through univariate and multivariate Cox regression analyses. Functional enrichment analysis and drug prediction were conducted for the identified biomarkers. Expression levels of candidate genes (GRIA2, FBXO32, GNG12, and PHLDA2) were validated using qRT-PCR. The biological function of GNG12 was investigated through gain- and loss-of-function studies in neuroblastoma cell lines.</p><p><strong>Results: </strong>The analysis identified 1,675 differentially expressed genes and two critical modules (MEblack and MEturquoise) through WGCNA. Four prognostic biomarkers (GRIA2, FBXO32, GNG12, and PHLDA2) were established and integrated into a nomogram with clinical parameters. Functional analysis revealed their involvement in extracellular matrix organization, DNA replication, and nucleocytoplasmic transport. Drug prediction identified potential therapeutic compounds targeting GRIA2 and FBXO32. Experimental validation demonstrated elevated expression of all four biomarkers in neuroblastoma cell lines compared to normal controls. Notably, GNG12 knockdown significantly suppressed while its overexpression enhanced proliferation and migration of SH-SY5Y cells.</p><p><strong>Conclusions: </strong>This study identified and validated four EM-related prognostic biomarkers in neuroblastoma, with GNG12 functionally implicated in tumor cell proliferation and migration. These findings provide potential therapeutic targets and prognostic indicators for neuroblastoma management.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of Methicillin-Resistant Staphylococcus Aureus Resistance and Hematological Profiles in Diabetic Foot Infections. 糖尿病足感染中耐甲氧西林金黄色葡萄球菌耐药性和血液学特征。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250438
Tian Chen, Tengteng Li, Jianhua Yu, Wenqing He, Qi Mu, Chao Qian

Background: This study aimed to analyze the infection rate, drug-resistant phenotypes, and hematological index profiles of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in patients with diabetic foot ulcers (DFUs). This study sought to provide insights for the early identification of MRSA infections and the optimization of antimicrobial strategies in patients with DFU.

Methods: The clinical data of patients with DFUs hospitalized from January 2022 through June 2023 were retrospectively reviewed. The detection rate and drug resistance profile of S. aureus were analyzed using bacterial culture and drug sensitivity testing. Additionally, the differences in hematological indices between the MRSA and MSSA infection groups were compared.

Results: A total of 1,385 patients with DFU underwent bacterial culture of secretions, with a positive rate of 50.25% (696/1,385) for pathogenic bacteria. The detection rate of S. aureus was 14.58% (202/1,385), out of which MRSA accounted for 38.12% (77/202). The MRSA group exhibited resistance to macrolides (clarithromycin: 64.94% vs. 36.00%; erythromycin: 70.13% vs. 39.20%; azithromycin: 66.23% vs. 38.40%), lincosamides (clindamycin: 68.83% vs. 31.20%), and quinolones (levofloxacin: 28.57% vs. 15.20%; moxifloxacin: 15.58% vs. 5.60%). These differences were statistically significant (all p < 0.05). Furthermore, hematological analysis revealed significant disparities between the two groups in erythrocyte mean corpuscular hemoglobin concentration (MCHC), D-dimer, albumin (ALB), alkaline phosphatase (ALP), and electrolytes (Na+, Cl-, Ca2+) (all p < 0.05).

Conclusions: This study examined the characteristics of DFU-associated MRSA infection, particularly its multidrug resistance features. MRSA infection demonstrated 100% sensitivity to vancomycin and linezolid. The findings suggest that combined detection of MCHC, D-dimer, ALB, ALP, Na+, Cl-, and Ca2+ may serve as a valuable reference for the early identification of DFU-associated MRSA infection in clinical settings. Clinicians should be mindful of MRSA infection risks in patients with DFU and develop individualized anti-infection regimens based on drug sensitivity profiles to improve prognosis.

背景:本研究旨在分析耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)在糖尿病足溃疡(DFUs)患者中的感染率、耐药表型和血液学指标。本研究旨在为DFU患者MRSA感染的早期识别和抗菌策略的优化提供见解。方法:回顾性分析2022年1月至2023年6月住院的DFUs患者的临床资料。采用细菌培养和药敏试验分析金黄色葡萄球菌的检出率和耐药谱。此外,比较MRSA感染组和MSSA感染组血液学指标的差异。结果:共1385例DFU患者进行分泌物细菌培养,病原菌阳性率为50.25%(696/ 1385)。金黄色葡萄球菌检出率为14.58%(202/ 1385),其中MRSA检出率为38.12%(77/202)。MRSA组对大环内酯类药物(克拉霉素:64.94% vs. 36.00%;红霉素:70.13% vs. 39.20%;阿奇霉素:66.23% vs. 38.40%)、林肯胺类药物(克林霉素:68.83% vs. 31.20%)和喹诺酮类药物(左氧氟沙星:28.57% vs. 15.20%;莫西沙星:15.58% vs. 5.60%)耐药。差异均有统计学意义(p < 0.05)。此外,血液学分析显示两组在红细胞平均红细胞血红蛋白浓度(MCHC)、d -二聚体、白蛋白(ALB)、碱性磷酸酶(ALP)和电解质(Na+、Cl-、Ca2+)方面存在显著差异(均p < 0.05)。结论:本研究探讨了与dfu相关的MRSA感染的特征,特别是其多药耐药特征。MRSA感染对万古霉素和利奈唑胺100%敏感。研究结果提示,联合检测MCHC、d -二聚体、ALB、ALP、Na+、Cl-和Ca2+可作为临床早期识别dfu相关MRSA感染的有价值参考。临床医生应注意DFU患者的MRSA感染风险,并根据药物敏感性制定个性化的抗感染方案,以改善预后。
{"title":"Characterization of Methicillin-Resistant Staphylococcus Aureus Resistance and Hematological Profiles in Diabetic Foot Infections.","authors":"Tian Chen, Tengteng Li, Jianhua Yu, Wenqing He, Qi Mu, Chao Qian","doi":"10.7754/Clin.Lab.2025.250438","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250438","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to analyze the infection rate, drug-resistant phenotypes, and hematological index profiles of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive S. aureus (MSSA) in patients with diabetic foot ulcers (DFUs). This study sought to provide insights for the early identification of MRSA infections and the optimization of antimicrobial strategies in patients with DFU.</p><p><strong>Methods: </strong>The clinical data of patients with DFUs hospitalized from January 2022 through June 2023 were retrospectively reviewed. The detection rate and drug resistance profile of S. aureus were analyzed using bacterial culture and drug sensitivity testing. Additionally, the differences in hematological indices between the MRSA and MSSA infection groups were compared.</p><p><strong>Results: </strong>A total of 1,385 patients with DFU underwent bacterial culture of secretions, with a positive rate of 50.25% (696/1,385) for pathogenic bacteria. The detection rate of S. aureus was 14.58% (202/1,385), out of which MRSA accounted for 38.12% (77/202). The MRSA group exhibited resistance to macrolides (clarithromycin: 64.94% vs. 36.00%; erythromycin: 70.13% vs. 39.20%; azithromycin: 66.23% vs. 38.40%), lincosamides (clindamycin: 68.83% vs. 31.20%), and quinolones (levofloxacin: 28.57% vs. 15.20%; moxifloxacin: 15.58% vs. 5.60%). These differences were statistically significant (all p < 0.05). Furthermore, hematological analysis revealed significant disparities between the two groups in erythrocyte mean corpuscular hemoglobin concentration (MCHC), D-dimer, albumin (ALB), alkaline phosphatase (ALP), and electrolytes (Na+, Cl-, Ca2+) (all p < 0.05).</p><p><strong>Conclusions: </strong>This study examined the characteristics of DFU-associated MRSA infection, particularly its multidrug resistance features. MRSA infection demonstrated 100% sensitivity to vancomycin and linezolid. The findings suggest that combined detection of MCHC, D-dimer, ALB, ALP, Na+, Cl-, and Ca2+ may serve as a valuable reference for the early identification of DFU-associated MRSA infection in clinical settings. Clinicians should be mindful of MRSA infection risks in patients with DFU and develop individualized anti-infection regimens based on drug sensitivity profiles to improve prognosis.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Combating Lipemia in Severe Hypertriglyceridemia Pancreatitis: Dilution and Centrifugal Tactics. 对抗严重高甘油三酯血症性胰腺炎中的脂血症:稀释和离心策略。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250421
Yinjie Lv, Jiehua Han

Background: Severe hypertriglyceridemia (HTG) is a critical risk factor for acute pancreatitis. Lipemic interference in laboratory testing complicates diagnosis and delays clinical intervention. This case highlights strategies to mitigate lipemia-induced analytical errors.

Methods: A 42-year-old male presented with severe abdominal pain and markedly elevated triglycerides (> 21.94 mmol/L). Lipemia interference was addressed via 1) 10-fold dilution for rapid lipid profiling and 2) high-speed centrifugation (15,000 rpm, 20 minutes) with repeated processing of the subnatant.

Results: Dilution provided preliminary lipid results within 2.5 hours, revealing extreme hypertriglyceridemia (77.72 mmol/L), prompting plasma exchange. Centrifugation corrected electrolyte and protein measurements (e.g., sodium: 128 - 137 mmol/L; total protein: 84.2 - 62.8 g/L).

Conclusions: Dilution and centrifugation are effective for rapid reporting and accurate analysis of lipemic samples. Standardized protocols for lipemia management are essential for timely clinical decision-making.

背景:重度高甘油三酯血症(HTG)是急性胰腺炎的重要危险因素。实验室检测中的血脂干扰使诊断复杂化并延误了临床干预。这个案例强调了减轻血脂引起的分析错误的策略。方法:42岁男性,腹痛严重,甘油三酯明显升高(> 21.94 mmol/L)。通过1)10倍稀释快速脂质分析和2)高速离心(15,000 rpm, 20分钟)反复处理下清液来解决脂血症干扰。结果:稀释后2.5小时内提供初步脂质结果,显示极度高甘油三酯血症(77.72 mmol/L),提示血浆置换。离心校正电解质和蛋白质测量值(例如,钠:128 - 137 mmol/L;总蛋白:84.2 - 62.8 g/L)。结论:稀释和离心是快速报告和准确分析血脂样品的有效方法。标准化的血脂管理方案对于及时的临床决策至关重要。
{"title":"Combating Lipemia in Severe Hypertriglyceridemia Pancreatitis: Dilution and Centrifugal Tactics.","authors":"Yinjie Lv, Jiehua Han","doi":"10.7754/Clin.Lab.2025.250421","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250421","url":null,"abstract":"<p><strong>Background: </strong>Severe hypertriglyceridemia (HTG) is a critical risk factor for acute pancreatitis. Lipemic interference in laboratory testing complicates diagnosis and delays clinical intervention. This case highlights strategies to mitigate lipemia-induced analytical errors.</p><p><strong>Methods: </strong>A 42-year-old male presented with severe abdominal pain and markedly elevated triglycerides (> 21.94 mmol/L). Lipemia interference was addressed via 1) 10-fold dilution for rapid lipid profiling and 2) high-speed centrifugation (15,000 rpm, 20 minutes) with repeated processing of the subnatant.</p><p><strong>Results: </strong>Dilution provided preliminary lipid results within 2.5 hours, revealing extreme hypertriglyceridemia (77.72 mmol/L), prompting plasma exchange. Centrifugation corrected electrolyte and protein measurements (e.g., sodium: 128 - 137 mmol/L; total protein: 84.2 - 62.8 g/L).</p><p><strong>Conclusions: </strong>Dilution and centrifugation are effective for rapid reporting and accurate analysis of lipemic samples. Standardized protocols for lipemia management are essential for timely clinical decision-making.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of Endoplasmic Reticulum Stress-Related Gene Signature Reveals KRT8 as a Target in Ovarian Cancer. 内质网应激相关基因特征的鉴定揭示KRT8是卵巢癌的靶点。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.241216
Xiaoyu Li, Wulin Shan, Wenju Peng, Qi Zhu, Xu Huang, Yao Chen, Zengying Wang, Bairong Xia

Background: Ovarian cancer (OC) is an invasive gynecological cancer with an overall 5-year survival rate of less than 45%. Endoplasmic reticulum (ER) stress plays a crucial role in regulating oncogenic events and immune-modulatory pathways, influencing malignant progression, antitumor immunity, and treatment response. However, the full scope of ER stress in ovarian cancer remains poorly understood and warrants further investigation.

Methods: RNA sequencing and clinical data were sourced from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus database (GEO). ER stress-related genes associated with ovarian tumor prognosis were identified, and an ER stress risk score model was developed using LASSO regression. We utilized this ER stress risk score to explore differences in immune cell infiltration. Furthermore, the biological role and expression of the risk gene KRT8 were validated through molecular biology experiments.

Results: We identified 573 genes related to ER stress that were differentially expressed genes (DEGs) between normal and tumor tissues. The ER stress-related risk signature (ERRS) constructed using the TCGA dataset was regarded as an independent and significant prognostic model for predicting cancer progression and instructing clinical decisions. Additionally, KRT8 was found to be overexpressed in ovarian cancer cells and tissues. Downregula-tion of KRT8 inhibited ovarian cancer cell proliferation and migration (in both SKOV3 and OVCAR8 cells) in vitro.

Conclusions: The ER stress-related gene model we developed can be utilized to assess the prognostic risk for OC patients. Importantly, KRT8 was identified as a key risk gene in ovarian cancer, promoting tumor progression, and holds potential as a novel therapeutic target.

背景:卵巢癌(OC)是一种侵袭性妇科肿瘤,总体5年生存率低于45%。内质网应激在调节肿瘤发生事件和免疫调节途径、影响恶性进展、抗肿瘤免疫和治疗反应中起着至关重要的作用。然而,内质网应激在卵巢癌中的全部范围仍然知之甚少,需要进一步的研究。方法:RNA测序和临床数据来源于Cancer Genome Atlas (TCGA)和Gene Expression Omnibus database (GEO)。鉴定与卵巢肿瘤预后相关的内质网应激相关基因,采用LASSO回归建立内质网应激风险评分模型。我们利用内质网应激风险评分来探讨免疫细胞浸润的差异。此外,通过分子生物学实验验证了危险基因KRT8的生物学作用和表达。结果:我们鉴定出573个与内质网应激相关的基因,这些基因是正常组织和肿瘤组织之间的差异表达基因(DEGs)。使用TCGA数据集构建的内质网应激相关风险特征(ERRS)被认为是预测癌症进展和指导临床决策的独立且重要的预后模型。此外,KRT8在卵巢癌细胞和组织中被发现过表达。KRT8的下调在体外抑制卵巢癌细胞(SKOV3和OVCAR8细胞)的增殖和迁移。结论:我们建立的内质网应激相关基因模型可用于评估OC患者的预后风险。重要的是,KRT8被确定为卵巢癌的关键风险基因,促进肿瘤进展,并具有作为新的治疗靶点的潜力。
{"title":"Identification of Endoplasmic Reticulum Stress-Related Gene Signature Reveals KRT8 as a Target in Ovarian Cancer.","authors":"Xiaoyu Li, Wulin Shan, Wenju Peng, Qi Zhu, Xu Huang, Yao Chen, Zengying Wang, Bairong Xia","doi":"10.7754/Clin.Lab.2025.241216","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.241216","url":null,"abstract":"<p><strong>Background: </strong>Ovarian cancer (OC) is an invasive gynecological cancer with an overall 5-year survival rate of less than 45%. Endoplasmic reticulum (ER) stress plays a crucial role in regulating oncogenic events and immune-modulatory pathways, influencing malignant progression, antitumor immunity, and treatment response. However, the full scope of ER stress in ovarian cancer remains poorly understood and warrants further investigation.</p><p><strong>Methods: </strong>RNA sequencing and clinical data were sourced from the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus database (GEO). ER stress-related genes associated with ovarian tumor prognosis were identified, and an ER stress risk score model was developed using LASSO regression. We utilized this ER stress risk score to explore differences in immune cell infiltration. Furthermore, the biological role and expression of the risk gene KRT8 were validated through molecular biology experiments.</p><p><strong>Results: </strong>We identified 573 genes related to ER stress that were differentially expressed genes (DEGs) between normal and tumor tissues. The ER stress-related risk signature (ERRS) constructed using the TCGA dataset was regarded as an independent and significant prognostic model for predicting cancer progression and instructing clinical decisions. Additionally, KRT8 was found to be overexpressed in ovarian cancer cells and tissues. Downregula-tion of KRT8 inhibited ovarian cancer cell proliferation and migration (in both SKOV3 and OVCAR8 cells) in vitro.</p><p><strong>Conclusions: </strong>The ER stress-related gene model we developed can be utilized to assess the prognostic risk for OC patients. Importantly, KRT8 was identified as a key risk gene in ovarian cancer, promoting tumor progression, and holds potential as a novel therapeutic target.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of Oscillation-Induced Depolymerization for Pseudothrombocytopenia Management Under Varying Conditions. 振荡诱导解聚治疗假性血小板减少症在不同条件下的疗效。
IF 0.6 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY Pub Date : 2025-12-01 DOI: 10.7754/Clin.Lab.2025.250420
Yunjiu Wang, Jinhu Guo, Wei Meng, Yan Huang

Background: The aim of this study is to examine the effectiveness of oscillation-induced depolymerization in mitigating pseudothrombocytopenia (PTCP) under varying oscillatory conditions.

Methods: A total of 161 patients diagnosed with PTCP and admitted between May 2020 and November 2023 were included in the study. The patients were categorized into four groups based on oscillation parameters: 1,500 rpm for 1 minute, 1,500 rpm for 3 minutes, 3,000 rpm for 1 minute, and 3,000 rpm for 3 minutes. Platelet (PLT) depo-lymerization was assessed pre- and post-oscillation in each group, and peripheral blood smears were examined to evaluate platelet distribution. Additionally, the Mindray BC-6800 Plus hematology analyzer, in combination with a special stain, was utilized to verify depolymerization and identify the most appropriate depolymerization method for clinical application.

Results: PLT counts were significantly higher in the 3,000 rpm for 3 minutes and the 3,000 rpm for 1 minute groups compared to the 1,500 rpm for 1 minute group (p < 0.05). However, no significant differences in white blood cell and red blood cell counts were observed across the oscillation conditions (p > 0.05). Depolymerization rates in the 3,000 rpm groups were significantly higher than those in the 1,500 rpm groups (p < 0.05). The oscillation-induced depolymerization rate in the 3,000 rpm for 3 minutes group reached 93.79%, which was significantly greater than that in the special stain group (11.80%) (p < 0.05). Logistic regression analysis identified elevated lymphocyte count and potassium level as risk factors for incomplete depolymerization, while total bilirubin, direct bilirubin, and indirect bilirubin levels were found to be protective factors (p < 0.05).

Conclusions: Oscillation at 3,000 rpm for 3 minutes resulted in the highest rate of platelet depolymerization and demonstrated favorable clinical efficacy for PTCP management. Monitoring of lymphocyte count, potassium, total bilirubin, direct bilirubin, and indirect bilirubin levels is essential to facilitate timely implementation of the oscillation method, thereby reducing the incidence of PTCP and enhancing the accuracy of clinical detection.

背景:本研究的目的是研究振荡诱导解聚在不同振荡条件下减轻假性血小板减少症(PTCP)的有效性。方法:在2020年5月至2023年11月期间,共纳入161例诊断为PTCP的患者。根据振荡参数将患者分为4组:1500转/分1分钟、1500转/分3分钟、3000转/分1分钟、3000转/分3分钟。评估各组振荡前后血小板(PLT)沉积情况,并检测外周血涂片以评估血小板分布。此外,使用迈瑞BC-6800 Plus血液分析仪结合特殊染色剂验证解聚,并确定最适合临床应用的解聚方法。结果:与1500 rpm 1分钟组相比,3000 rpm 3分钟组和3000 rpm 1分钟组PLT计数显著高于1500 rpm 1分钟组(p < 0.05)。然而,在不同的振荡条件下,白细胞和红细胞计数没有显著差异(p < 0.05)。3000转/分组的解聚速率显著高于1500转/分组(p < 0.05)。振荡诱导解聚率在3000转/分3分钟组达到93.79%,显著高于特殊染色组(11.80%)(p < 0.05)。Logistic回归分析发现淋巴细胞计数和钾水平升高是不完全解聚的危险因素,而总胆红素、直接胆红素和间接胆红素水平是保护因素(p < 0.05)。结论:3000rpm振荡3min,血小板解聚率最高,对PTCP治疗有良好的临床疗效。监测淋巴细胞计数、钾、总胆红素、直接胆红素和间接胆红素水平,有利于及时实施振荡法,从而降低PTCP的发病率,提高临床检测的准确性。
{"title":"Efficacy of Oscillation-Induced Depolymerization for Pseudothrombocytopenia Management Under Varying Conditions.","authors":"Yunjiu Wang, Jinhu Guo, Wei Meng, Yan Huang","doi":"10.7754/Clin.Lab.2025.250420","DOIUrl":"https://doi.org/10.7754/Clin.Lab.2025.250420","url":null,"abstract":"<p><strong>Background: </strong>The aim of this study is to examine the effectiveness of oscillation-induced depolymerization in mitigating pseudothrombocytopenia (PTCP) under varying oscillatory conditions.</p><p><strong>Methods: </strong>A total of 161 patients diagnosed with PTCP and admitted between May 2020 and November 2023 were included in the study. The patients were categorized into four groups based on oscillation parameters: 1,500 rpm for 1 minute, 1,500 rpm for 3 minutes, 3,000 rpm for 1 minute, and 3,000 rpm for 3 minutes. Platelet (PLT) depo-lymerization was assessed pre- and post-oscillation in each group, and peripheral blood smears were examined to evaluate platelet distribution. Additionally, the Mindray BC-6800 Plus hematology analyzer, in combination with a special stain, was utilized to verify depolymerization and identify the most appropriate depolymerization method for clinical application.</p><p><strong>Results: </strong>PLT counts were significantly higher in the 3,000 rpm for 3 minutes and the 3,000 rpm for 1 minute groups compared to the 1,500 rpm for 1 minute group (p < 0.05). However, no significant differences in white blood cell and red blood cell counts were observed across the oscillation conditions (p > 0.05). Depolymerization rates in the 3,000 rpm groups were significantly higher than those in the 1,500 rpm groups (p < 0.05). The oscillation-induced depolymerization rate in the 3,000 rpm for 3 minutes group reached 93.79%, which was significantly greater than that in the special stain group (11.80%) (p < 0.05). Logistic regression analysis identified elevated lymphocyte count and potassium level as risk factors for incomplete depolymerization, while total bilirubin, direct bilirubin, and indirect bilirubin levels were found to be protective factors (p < 0.05).</p><p><strong>Conclusions: </strong>Oscillation at 3,000 rpm for 3 minutes resulted in the highest rate of platelet depolymerization and demonstrated favorable clinical efficacy for PTCP management. Monitoring of lymphocyte count, potassium, total bilirubin, direct bilirubin, and indirect bilirubin levels is essential to facilitate timely implementation of the oscillation method, thereby reducing the incidence of PTCP and enhancing the accuracy of clinical detection.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 12","pages":""},"PeriodicalIF":0.6,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145707568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical laboratory
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1